Global Cord Blood (NYSE:CO) Shares Cross Above 200 Day Moving Average of $0.00

Global Cord Blood Corp (NYSE:CO)’s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.00 and traded as high as $5.52. Global Cord Blood shares last traded at $5.49, with a volume of 600 shares changing hands.

The firm has a market capitalization of $679.47 million, a P/E ratio of 15.97 and a beta of 0.20. The company’s 50 day simple moving average is $5.75.

Global Cord Blood (NYSE:CO) last announced its quarterly earnings data on Tuesday, June 18th. The medical research company reported $0.11 earnings per share (EPS) for the quarter. Global Cord Blood had a net margin of 29.56% and a return on equity of 8.84%. The company had revenue of $37.50 million during the quarter.

Large investors have recently bought and sold shares of the stock. BlackRock Inc. raised its holdings in Global Cord Blood by 2,935.0% during the 4th quarter. BlackRock Inc. now owns 7,284 shares of the medical research company’s stock valued at $47,000 after buying an additional 7,044 shares during the last quarter. Lingohr & Partner Asset Management GmbH bought a new stake in Global Cord Blood during the 1st quarter valued at $422,000. SG Americas Securities LLC bought a new stake in Global Cord Blood during the 1st quarter valued at $758,000. Norges Bank bought a new stake in Global Cord Blood during the 4th quarter valued at $4,156,000. Finally, Jayhawk Capital Management L.L.C. bought a new stake in Global Cord Blood during the 1st quarter valued at $94,246,000. Institutional investors own 17.08% of the company’s stock.

About Global Cord Blood (NYSE:CO)

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services.

See Also: Candlestick

Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.